The South and Central America extracellular matrix market was valued at US$ 989.99 thousand in 2019 and is projected to reach US$ 11,708.44 thousand by 2027; it is expected to grow at a CAGR of 7.1% from 2020 to 2027.
The growth of the market is attributed to the increasing incidences of trauma and cardiovascular diseases, and increasing vascular reconstruction procedures. However, the challenges associated with the usage of decellularized extracellular matrix such as , insufficient preservation of vasculature and extracellular matrix composition hinders the growth of the market.
The significantly rising incidences of the orthopaedic trauma conditions and cardiovascular diseases among others are the leading factors for the South and Central America Extracellular Matrix market growth. As a part of the treatment extracellular matrix serve several advantages for treating different chronic injuries caused due to surgery, accidents, chronic diseases and others. Chronic diseases such as cancer, heart diseases, musculoskeletal diseases, and others are the leading causes of death and disability. The awareness about the technologically advanced treatment and minimally invasive procedures demands treatments that are effective in less time. Thus, one of the advantages of the extracellular matrix serve the demand of the patients.
Additionally, the COVID-19 outbreak is negatively impacting the overburdened and underfunded healthcare systems of South and Central America. Hospitals are already overstressed by the treatment of vector‐borne diseases and community‐acquired infections and high rates of non‐communicable diseases (NCDs). Since the onset of the COVID-19, the prevention and treatment of NCDs such as diabetes and its associated complications have been critically affected in the region, as per the Pan American Health Organization (PAHO).
South and Central America Extracellular Matrix Market Revenue and Forecast to 2027 (US$ Thousand)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
South and Central America Extracellular Matrix Market Segmentation
By Application
- Vascular Repair and Reconstruction
- Dural Repair
- Wound Healing
- Cardiac Repair
- Pericardial Repair
- Soft Tissue Repair
By Raw Material
- Bovine
- Porcine
- Other Raw Material
Company Profiles
- Organogenesis Inc.
- Integra Life Sciences Corporation
- Mölnlycke Health Care AB
- Anika Therapeutics, Inc.
- ACell Inc.
- MIROMATRIX MEDICAL Inc
- Acera Surgical Inc., CorMatrix, Inc.
- Hollister Incorporated
- MLM Biologics Inc.
- Harbor MedTech, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Application, Raw Material, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Brazil, Argentina
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Extracellular Matrix Market – By Application
1.3.2 Extracellular Matrix Market – By Raw Material
1.3.3 South and Central America Extracellular Matrix Market
2. Extracellular Matrix Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Extracellular Matrix Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South and Central America – PEST Analysis
4.3 Expert Opinion
5. South and Central America Extracellular Matrix Market Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidences of Trauma and Cardiovascular Diseases
5.1.2 Increasing Vascular Reconstruction Procedures
5.2 Key Market challenge
5.2.1 Challenges Associated with the Usage of Decellularized Extracellular Matrix
5.3 Key Market Opportunity
5.3.1 Opportunities to Treat Cancer
5.4 Future Trend
5.4.1 3D Printing in Wound Care Management
5.5 Impact analysis
6. Extracellular Matrix Market – South and Central America Analysis
6.1 South and Central America Extracellular Matrix market Revenue Forecasts and Analysis (us$ Thousand)
6.3 Market Positioning of Key Players
7. South and Central America Extracellular Matrix Market Analysis – By Application
7.1 Overview
7.2 South and Central America Extracellular Matrix Market Shares By Application, 2019 & 2027 (%)
7.3 VASCULAR REPAIR AND RECONSTRUCTION MARKET
7.3.1 Overview
7.3.2 Vascular Repair and Reconstruction Market: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
7.4 DURAL REPAIR MARKET
7.4.1 Overview
7.4.2 Dural Repair: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
7.5 WOUND HEALING MARKET
7.5.1 Overview
7.5.2 Wound Healing: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
7.6 CARDIAC REPAIR MARKET
7.6.1 Overview
7.6.2 Cardiac Repair: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
7.7 PERICARDIAL REPAIR MARKET
7.7.1 Overview
7.7.2 Pericardial Repair: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
7.8 SOFT TISSUE REPAIR MARKET
7.8.1 Overview
7.8.2 Soft Tissue Repair: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
8. South and Central America Extracellular Matrix Market Analysis – By Raw Material
8.1 Overview
8.2 South and Central America Extracellular Matrix Market Shares By Raw Material, 2019 & 2027 (%)
8.3 BOVINE MARKET
8.3.1 Overview
8.3.2 Bovine: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
8.4 PORCINE MARKET
8.4.1 Overview
8.4.2 Porcine: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
8.5 OTHERS MARKET
8.5.1 Overview
8.5.2 Others: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
9. South and Central America Extracellular Matrix Market Revenue and Forecasts to 2027
9.1 Overview
9.1.1 South and Central America: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.2 South and Central America Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
9.1.3 South and Central America Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
9.1.4 South and Central America: Extracellular Matrix Market, by Country, 2019 & 2027 (%)
9.1.5 Brazil: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.5.1 Brazil: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.6 Brazil Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
9.1.7 Brazil Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
9.1.8 Argentina: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.8.1 Argentina: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.9 Argentina Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
9.1.10 Argentina Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
9.1.11 Central America: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.11.1 Central America: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.12 Central America Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
9.1.13 Central America Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
9.1.13.1 El Salvador: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.13.2 El Salvador: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.13.3 El Salvador Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
9.1.13.4 El Salvador Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
9.1.13.5 Guatemala: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.13.6 Guatemala: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.13.7 Guatemala Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
9.1.13.8 Guatemala Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
9.1.13.9 Rest of Central America: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.13.10 Rest of Central America: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.13.11 Rest of Central America Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
9.1.13.12 Rest of Central America Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
9.1.14 Rest of South America: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.14.1 Rest of South America: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.15 Rest of South America Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
9.1.16 Rest of South America Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
10. Impact of COVID-19 Pandemic on South and Central America Extracellular Matrix Market
10.1 South and Central America: Impact Assessment of COVID-19 Pandemic
11. Extracellular Matrix Market – Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Organogenesis Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Integra Life Sciences Corporation
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Mölnlycke Health Care AB.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Anika Therapeutics, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 ACell Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 MIROMATRIX MEDICAL Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Acera Surgical Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 CorMatrix, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Hollister Incorporated
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.10 MLM Biologics Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Harbor MedTech, Inc.
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. South and Central America Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
Table 2. South and Central America Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
Table 3. Brazil Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
Table 4. Brazil Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
Table 5. Argentina Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
Table 6. Argentina Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
Table 7. Central America Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
Table 8. Central America Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
Table 9. El Salvador Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
Table 10. El Salvador Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
Table 11. Guatemala Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
Table 12. Guatemala Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
Table 13. Rest of Central America Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
Table 14. Rest of Central America Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
Table 15. Rest of South America Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
Table 16. Rest of South America Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
Table 17. Organic Developments Done By Companies
Table 18. Inorganic Developments Done By Companies
Table 19. Glossary of Terms, Extracellular Matrix market
LIST OF FIGURES
Figure 1. Extracellular Matrix Market Segmentation
Figure 2. Extracellular Matrix Market– By Geography
Figure 3. South and Central America Extracellular Matrix Market Overview
Figure 4. Soft Tissue Repair Segment Held Largest Share of Extracellular Matrix Market
Figure 5. Brazil Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. South and Central America Extracellular Matrix Market, Industry Landscape
Figure 7. South and Central America PEST Analysis
Figure 8. Extracellular Matrix market impact analysis of driver and restraints
Figure 9. South and Central America Extracellular Matrix market – Revenue Forecasts and Analysis – 2019- 2027 (US$ Thousand)
Figure 10. Market Positioning of Key Players
Figure 11. South and Central America Extracellular Matrix market Shares By Application, 2019 & 2027 (%)
Figure 12. Vascular Repair and Reconstruction Market: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
Figure 13. Dural Repair: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
Figure 14. Wound Healing: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
Figure 15. Cardiac Repair: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
Figure 16. Pericardial Repair: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
Figure 17. Soft Tissue Repair: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
Figure 18. South and Central America Extracellular Matrix Market Shares By Raw Material, 2019 & 2027 (%)
Figure 19. Bovine: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
Figure 20. Porcine: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
Figure 21. Others: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
Figure 22. South and Central America: Extracellular Matrix Market, by Key Country – Revenue (2019) (USD Million)
Figure 23. South and Central America Extracellular Matrix Market Revenue and Forecast to 2027 (USD Thousand)
Figure 24. South and Central America: Extracellular Matrix Market, by Country, 2019 & 2027 (%)
Figure 25. Brazil: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 26. Argentina: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 27. Central America: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 28. El Salvador: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 29. Guatemala: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 30. Rest of Central America: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 31. Rest of South America: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 32. Impact of COVID-19 Pandemic on Extracellular Matrix Market in South and Central America
Figure 33. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - South and Central America Extracellular Matrix Market
- Organogenesis Inc.
- Integra Life Sciences Corporation
- Mölnlycke Health Care AB
- Anika Therapeutics, Inc.
- ACell Inc.
- MIROMATRIX MEDICAL Inc
- Acera Surgical Inc., CorMatrix, Inc.
- Hollister Incorporated
- MLM Biologics Inc.
- Harbor MedTech, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to South and Central America Extracellular Matrix Market
Dec 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Dec 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Dec 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Dec 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Dec 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)